Diseases associated with altered ryanodine receptor activity

Subcellular Biochemistry

Volumn 45, Issue , 2007, Pages 273-321

  Durham, W J ^a   Wehrens, X H T ^a   Sood, S ^a   Hamilton, S L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

And atrial fibrillation; And catecholaminergic polymorphic ventricular tachycardia arrhythmogenic right ventricular dysplasia type 2; Calcium homeostasis; Cardiomyopathy; Central core disease; Excitation contraction coupling; Heart failure; Malignant hyperthermia; Multi minicore disease; Sudden death

Indexed keywords

CALCIUM; RYANODINE RECEPTOR;

CARDIOMYOPATHY; CENTRAL CORE DISEASE; DIABETIC ANGIOPATHY; GENETICS; HEART ARRHYTHMIA; HEART FAILURE; HEAT STROKE; HOMEOSTASIS; HUMAN; MALIGNANT HYPERTHERMIA; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE;

ARRHYTHMIAS, CARDIAC; CALCIUM; CARDIOMYOPATHIES; DIABETIC ANGIOPATHIES; HEART FAILURE; HEAT STROKE; HOMEOSTASIS; HUMANS; MALIGNANT HYPERTHERMIA; MUSCLE, STRIATED; MUTATION; MYOPATHY, CENTRAL CORE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 38849158662     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4020-6191-2_10     Document Type: Article

References (248)

1. Aizawa, Y., Ueda, K., Komura, S., Washizuka, T., Chinushi, M., Inagaki, N., Matsumoto, Y., Hayashi, T. and M. Takahashi, Nakano, N., Yasunami, M., Kimura, A., and Hiraoka, M. (1984). "A Protocol for the Investigation of Malignant Hyperpyrexia (MH) Susceptibility. The European Malignant Hyperpyrexia Group. " Br J Anaesth 56(11): 1267-9.
2. Aizawa, Y., Ueda, K., Komura, S., Washizuka, T., Chinushi, M., Inagaki, N., Matsumoto, Y., Hayashi, T. and M. Takahashi, Nakano, N., Yasunami, M., Kimura, A., and Hiraoka, M. (2005). "A Novel Mutation in FKBP12. 6 Binding Region of the Human Cardiac Ryanodine Receptor Gene (R2401H) in a Japanese Patient with Catecholaminergic Polymorphic Ventricular Tachycardia. " Int J Cardiol 99(2): 343-5.
3. Apkon, M. (2003). Cellular Physiology of Skeletal, Cardiac, and Smooth Muscle. Medical Physiology: A Cellular and Molecular Approach. W. Boron, Boulpaep. Philadephia, Saunders: 230-254.
4. Avila, G., and Dirksen, R. T. (2001a). "Functional Effects of Central Core Disease Mutations in the Cytoplasmic Region of the Skeletal Muscle Ryanodine Receptor. " J Gen Physiol 118(3): 277-90.
5. Avila, G., O'Brien, J. J., and Dirksen, R. T. (2001b). "Excitation-Contraction Uncoupling by a Human Central Core Disease Mutation in the Ryanodine Receptor. " Proc Natl Acad Sci U S A 98(7): 4215-20.
6. Avila, G., O'Connell, K. M., Dirksen, R. T. (2003). "The Pore Region of the Skeletal Muscle Ryanodine Receptor is a Primary Locus for Excitation-Contraction Uncoupling in Central Core Disease. " J Gen Physiol 121(4): 277-86.
7. Awad, M. M., Dalal, D., Cho, E., Amat-Alarcon, N., James, C., Tichnell, C., Tucker, A., Russell, S. D., Bluemke, D. A., Dietz, H. C., Calkins, H., and Judge, D. P. (2006). "DSG2 Mutations Contribute to Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. " Am J Hum Genet 79(1): 136-42.
8. Baartscheer, A., Schumacher, C. A., van Borren, M. M., Belterman, C. N., Coronel, R., Opthof, T., and Fiolet, J. W. (2005). "Chronic Inhibition of Na+/H+-Exchanger Attenuates Cardiac Hypertrophy and Prevents Cellular Remodeling in Heart Failure. " Cardiovasc Res 65(1): 83-92.
9. Bagattin, A., Veronese, C., Bauce, B., Wuyts, W., Settimo, L., Nava, A., Rampazzo, A., and Danieli, G. A. (2004). "Denaturing HPLC-Based Approach for Detecting RYR2 Mutations Involved in Malignant Arrhythmias. " Clin Chem 50(7): 1148-55.
10. Barone, V., Massa, O., Intravaia, E., Bracco, A., Di Martino, A., Tegazzin, V., Cozzolino, S., and Sorrentino, V. (1999). "Mutation Screening of the RYR1 Gene and Identification of Two Novel Mutations in Italian Malignant Hyperthermia Families. " J Med Genet 36(2): 115-8.
11. Bauce, B., Rampazzo, A., Basso, C., Bagattin, A., Daliento, L., Tiso, N., Turrini, P., Thiene, G., Danieli, G. A., and Nava, A. (2002). "Screening for Ryanodine Receptor Type 2 Mutations in Families with Effort-Induced Polymorphic Ventricular Arrhythmias and Sudden Death: Early Diagnosis of Asymptomatic Carriers. " J Am Coll Cardiol 40(2): 341-9.
12. Bendahan, D., Kozak-Ribbens, G., Confort-Gouny, S., Ghattas, B., Figarella-Branger, D., Aubert, M., and Cozzone, P. J. (2001). "A Noninvasive Investigation of Muscle Energetics Supports Similarities Between Exertional Heat Stroke and Malignant Hyperthermia. " Anesth Analg 93(3): 683-9.
13. Bers, D. M. (2002a). "Cardiac Excitation-Contraction Coupling. " Nature 415(6868): 198-205.
14. Bers, D. M., and Bridge, J. H. (1989). "Relaxation of Rabbit Ventricular Muscle by Na-Ca Exchange and Sarcoplasmic Reticulum Calcium Pump. Ryanodine and Voltage Sensitivity. " Circ Res 65(2): 334-42.
15. Bers, D. M., and Guo, T. (2005). "Calcium Signaling in Cardiac Ventricular Myocytes. " Ann N Y Acad Sci 1047: 86-98.
16. Bers, D. M., Eisner, D. A., and Valdivia, H. H. (2003). "Sarcoplasmic Reticulum Ca2+ and Heart Failure: Roles of Diastolic Leak and Ca2+ Transport. " Circ Res 93(6): 487-90.
17. Bers, D. M., Pogwizd, S. M., and Schlotthauer, K. (2002b). "Upregulated Na/Ca Exchange is Involved in both Contractile Dysfunction and Arrhythmogenesis in Heart Failure. " Basic Res Cardiol 97 Suppl 1: I36-42.
18. Bethlem, J., van Wijngaarden, G. K., Meijer, A. E., and Fleury, P. (1971). "Observations on Central Core Disease. " J Neurol Sci 14(3): 293-9.
19. Bidasee, K. R., Dincer, U. D., Besch, H. R., Jr. (2001). "Ryanodine Receptor Dysfunction in Hearts of Streptozotocin-Induced Diabetic Rats. " Mol Pharmacol 60(6): 1356-64.
20. Bidasee, K. R., Ingersoll, S., Shao, C. H. (2005). Ryanodine Receptor Dysfunction in the Diabetic Heart. Ryanodine Receptors: Structure, Function and Dysfunction in Clinical Disease. X. H. Wehrens and A. R. Marks. New York, U. S. A., Springer, Inc. 254: 209-218.
21. Bidasee, K. R., Nallani, K., Besch, H. R., Jr., and Dincer, U. D. (2003a). "Streptozotocin-Induced Diabetes Increases Disulfide Bond Formation on Cardiac Ryanodine Receptor (RyR2). " J Pharmacol Exp Ther 305(3): 989-98.
22. Bidasee, K. R., Nallani, K., Yu, Y., Cocklin, R. R., Zhang, Y., Wang, M., Dincer, U. D., and Besch, H. R., Jr. (2003b). "Chronic Diabetes Increases Advanced Glycation end Products on Cardiac Ryanodine Receptors/Calcium-Release Channels. " Diabetes 52(7): 1825-36.
23. Bouchama, A., and Knochel, J. P. (2002). "Heat Stroke. " N Engl J Med 346(25): 1978-88.
24. Bouchard, R. A., and Bose, D. (1991). "Influence of Experimental Diabetes on Sarcoplasmic Reticulum Function in Rat Ventricular Muscle. " Am J Physiol 260(2 Pt 2): H341-54.
25. Brandl, C. J., deLeon, S., Martin, D. R., and MacLennan, D. H. (1987). "Adult forms of the Ca2+ATPase of Sarcoplasmic Reticulum. Expression in Developing Skeletal Muscle. " J Biol Chem 262(8): 3768-74.
26. Brandt, A., Schleithoff, L., Jurkat-Rott, K., Klingler, W., Baur, C., and Lehmann-Horn, F. (1999). "Screening of the Ryanodine Receptor Gene in 105 Malignant Hyperthermia Families: Novel Mutations and Concordance With the in Vitro Contracture Test. " Hum Mol Genet 8(11): 2055-62.
27. Brini, M. (2004). "Ryanodine Receptor Defects in Muscle Genetic Diseases. " Biochem Biophys Res Commun 322(4): 1245-55.
28. Britt, BA (1991) " Malignant Hyperthermia-A Review" Thermoregulation: Pathology, Pharmacology and Therapy (Schonbaum, E and Lomax, P eds) Pergamon Press, New York, USA, pp 179-292.
29. Brown, R. L., Pollock, A. N., Couchman, K. G., Hodges, M., Hutchinson, D. O., Waaka, R., Lynch, P., McCarthy, T. V., and Stowell, K. M. (2000). "A Novel Ryanodine Receptor Mutation and Genotype-Phenotype Correlation in a Large Malignant Hyperthermia New Zealand Maori Pedigree. " Hum Mol Genet 9(10): 1515-24.
30. Brundel, B. J., van Gelder, I. C., Henning, R. H., Tuinenburg, A. E., Deelman, L. E., Tieleman, R. G., Grandjean, J. G., van Gilst, W. H., and Crijns, H. J. (1999). "Gene Expression of Proteins Influencing the Calcium Homeostasis in Patients with Persistent and Paroxysmal Atrial Fibrillation. " Cardiovasc Res 42(2): 443-54.
31. Bull, R., and Marengo, J. J. (1993). "Sarcoplasmic Reticulum Release Channels from Frog Skeletal Muscle Display two Types of Calcium Dependence. " FEBS Lett 331(3): 223-7.
32. Cerrone, M., Colombi, B., Santoro, M., di Barletta, M. R., Scelsi, M., Villani, L., Napolitano, C., and Priori, S. G. (2005). "Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-in Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor. " Circ Res 96(10): e77-82.
33. Chamley, D., Pollock, N. A., Stowell, K. M., and Brown, R. L. (2000). "Malignant Hyperthermia in Infancy and Identification of Novel RYR1 Mutation. " Br J Anaesth 84(4): 500-4.
34. Chelu, M. G., Danila, C. I., Gilman, C. P., and Hamilton, S. L. (2004). "Regulation of Ryanodine Receptors by FK506 Binding Proteins. " Trends Cardiovasc Med 14(6): 227-34.
35. Chelu, M. G., Goonasekera, S. A., Durham, W. J., Tang, W., Lueck, J. D., Riehl, J., Pessah, I. N., Zhang, P., Bhattacharjee, M. B., Dirksen, R. T., and Hamilton, S. L. (2006). "Heat-and Anesthesia-Induced Malignant Hyperthermia in an RyR1 Knock-In Mouse. " Faseb J 20(2): 329-30.
36. Cheong, E., Tumbev, V., and Stoyanovsky, D. and G. Salama (2005). "Effects of pO2 on the Activation of Skeletal Muscle Ryanodine Receptors by NO: A Cautionary Note. " Cell Calcium 38(5): 481-8.
37. Choi, K. M., Zhong, Y., Hoit, B. D., Grupp, I. L., Hahn, H., Dilly, K. W., Guatimosim, S., Lederer, W. J., and Matlib, M. A. (2002). "Defective Intracellular Ca(2+) Signaling Contributes to Cardiomyopathy in Type 1 Diabetic Rats. " Am J Physiol Heart Circ Physiol 283(4): H1398-408.
38. Christ, T., Boknik, P., Wohrl, S., Wettwer, E., Graf, E. M., Bosch, R. F., Knaut, M., Schmitz, W., Ravens, U., and Dobrev, D. (2004). "L-Type Ca2+ Current Downregulation in Chronic Human Atrial Fibrillation is Associated with Increased Activity of Protein Phosphatases. " Circulation 110(17): 2651-7.
39. Chu, A., Diaz-Munoz, M., Hawkes, M. J., Brush, K., and Hamilton, S. L. (1990). "Ryanodine as a Probe For the Functional State of the Skeletal Muscle Sarcoplasmic Reticulum Ca2+ Release Channel. " Mol. Pharmocol. 37: 735-741.
40. Chu, A., Fill, M., Stefani, E., and Entman, M. L. (1993). "Cytoplasmic Ca2+ Does not Inhibit the Cardiac Muscle Sarcoplasmic Reticulum Ryanodine Receptor Ca2+ Channel, Although Ca(2+)-induced Ca2+ Inactivation of Ca2+ Release is Observed in Native Vesicles. " J Membr Biol 135(1): 49-59.
41. Chu, G., and Kranias, E. G. (2006). "Phospholamban as a Therapeutic Modality in Heart Failure. " Novartis Found Symp 274: 156-71; discussion 172-5, 272-6.
42. Cooper, C. E., Vollaard, N. B., Choueiri, T., and Wilson, M. T. (2002). "Exercise, Free Radicals and Oxidative Stress. " Biochem Soc Trans 30(2): 280-5.
43. Copello, J. A., Barg, S., Onoue, H., and Fleischer, S. (1997). "Heterogeneity of Ca2+ Gating of Skeletal Muscle and Cardiac Ryanodine Receptors. " Biophys J 73(1): 141-56.
44. Coronado, R., Morrissette, J., Sukhareva, M., Vaughan, D. M. (1994). "Structure and Function of Ryanodine Receptors. " Am J Physiol 266(6 Pt 1): C1485-504.
45. Corrado, D., Basso, C., Thiene, G., McKenna, W. J., Davies, M. J., Fontaliran, F., Nava, A., Silvestri, F., Blomstrom-Lundqvist, C., Wlodarska, E. K., Fontaine, G., and Camerini, F. (1997). "Spectrum of Clinicopathologic Manifestations of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: a Multicenter Study. " J Am Coll Cardiol 30(6): 1512-20.
46. Corrado, D., Thiene, G. (2006). "Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Clinical Impact of Molecular Genetic Studies. " Circulation 113(13): 1634-7.
47. Crean, R. D., Davis, S. A., Von Huben, S. N., Lay, C. C., Katner, S. N., and Taffe, M. A. (2006). "Effects of (+/-)3, 4-Methylenedioxymethamphetamine, (+/-)3, 4-Methylenedioxyamphetamine and Methamphetamine on Temperature and Activity in Rhesus Macaques. " Neuroscience 142(2): 515-25.
48. Creighton, W., Virmani, R., Kutys, R., and Burke, A. (2006). "Identification of Novel Missense Mutations of Cardiac Ryanodine Receptor Gene in Exercise-Induced Sudden Death at Autopsy. " J Mol Diagn 8(1): 62-7.
49. Currie, S., Loughrey, C. M., Craig, M. A., and Smith, G. L. (2004). "Calcium/Calmodulin-Dependent Protein Kinase IIdelta Associates with the Ryanodine Receptor Complex and Regulates Channel Function in Rabbit Heart. " Biochem J 377(Pt 2): 357-66.
50. d'Amati, G., Bagattin, A., Bauce, B., Rampazzo, A., Autore, C., Basso, C., King, K., Romeo, M. D., Gallo, P., Thiene, G., Danieli, G. A., and Nava, A. (2005). "Juvenile Sudden Death in a Family with Polymorphic Ventricular Arrhythmias Caused by a Novel RyR2 Gene Mutation: Evidence of Specific Morphological Substrates. " Hum Pathol 36(7): 761-7.
51. Danieli, G. A., and Rampazzo, A. (2002). "Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy. " Curr Opin Cardiol 17(3): 218-21.
52. Davis, M., Brown, R., Dickson, A., Horton, H., James, D., Laing, N., Marston, R., Norgate, M., Perlman, D. and N. Pollock, Stowell, K. (2002). "Malignant Hyperthermia Associated with Exercise-Induced Rhabdomyolysis or Congenital Abnormalities and a Novel RYR1 Mutation in New Zealand and Australian Pedigrees. " Br J Anaesth 88(4): 508-15.
53. Davis, M. R., Haan, E., Jungbluth, H., Sewry, C., North, K., Muntoni, F., Kuntzer, T., Lamont, P., Bankier, A., Tomlinson, P., Sanchez, A., Walsh, P., Nagarajan, L., Oley, C., Colley, A., Gedeon, A., Quinlivan, R., Dixon, J., James, D., Muller, C. R., and Laing, N. G. (2003). "Principal Mutation Hotspot for Central Core Disease and Related Myopathies in the C-Terminal Transmembrane Region of the RYR1 Gene. " Neuromuscul Disord 13(2): 151-7.
54. Denborough, M. A., Forster, J. F., Lovell, R. R., Maplestone, P. A., and Villiers. J. D. (1962). "Anaesthetic Deaths in a Family. " Br J Anaesth 34: 395-96.
55. Dirksen, R., and Avila, G. (2004). Pathophysiology of Muscle Disorders Linked to Mutations in the Skeletal Muscle Ryanodine Receptor. New York, Kluwer Academic Publisher.
56. Dirksen, R. T. (2002a). "Bi-Directional Coupling Between Dihydropyridine Receptors and Ryanodine Receptors. " Front Biosci 7: d659-70.
57. Dirksen, R. T., and Avila, G. (2002b). "Altered Ryanodine Receptor Function in Central Core Disease: Leaky or Uncoupled Ca(2+) Release Channels?" Trends Cardiovasc Med 12(5): 189-97.
58. Dobrev, D. (2006). "Electrical Remodeling in Atrial Fibrillation. " Herz 31(2): 108-12; quiz 42-3.
59. Dodge, K. L., Khouangsathiene, S., Kapiloff, M. S., Mouton, R., Hill, E. V., Houslay, M. D., Langeberg, L. K., and Scott, J. D. (2001). "mAKAP Assembles a Protein Kinase A/PDE4 Phosphodiesterase cAMP Signaling Module. " Embo J 20(8): 1921-30.
60. Du, G. G., Khanna, V. K., Guo, X., and MacLennan, D. H. (2004). "Central Core Disease Mutations R4892W, I4897T and G4898E in the Ryanodine Receptor Isoform 1 Reduce the Ca2+ Sensitivity and Amplitude of Ca2+-Dependent Ca2+ Release. " Biochem J 382(Pt 2): 557-64.
61. Du, G. G., Sandhu, B., Khanna, V. K., Guo, X. H., and MacLennan, D. H. (2002). "Topology of the Ca2+ Release Channel of Skeletal Muscle Sarcoplasmic Reticulum (RyR1). " Proc Natl Acad Sci U S A 99(26): 16725-30.
62. Ducreux, S., Zorzato, F., Ferreiro, A., Jungbluth, H., Muntoni, F., Monnier, N., Muller, C. R., and Treves, S., (2006). "Functional Properties of Ryanodine Receptors Carrying Three Amino Acid Substitutions Identified in Patients Affected by Multi-Minicore Disease and Central Core Disease, Expressed in Immortalized Lymphocytes. " Biochem J 395(2): 259-66.
63. Ducreux, S., Zorzato, F., Muller, C., Sewry, C., Muntoni, F., Quinlivan, R., Restagno, G., Girard, T., and Treves, S. (2004). "Effect of Ryanodine Receptor Mutations on Interleukin-6 Release and Intracellular Calcium Homeostasis in Human Myotubes from Malignant Hyperthermia-Susceptible Individuals and Patients Affected by Central Core Disease. " J Biol Chem 279(42): 43838-46.
64. Eisner, D. A., and Trafford, A. W. (2002). "Heart Failure and the Ryanodine Receptor: Does Occam's Razor Rule?" Circ Res 91(11): 979-81.
65. El-Armouche, A., Boknik, P., Eschenhagen, T., Carrier, L., Knaut, M., Ravens, U., and Dobrev, D. (2006). "Molecular Determinants of Altered Ca2+ Handling in Human Chronic Atrial Fibrillation. " Circulation 114(7): 670-80.
66. Eu, J. P., Sun, J., Xu, L., Stamler, J. S., and Meissner, G. (2000). "The Skeletal Muscle Calcium Release Channel: Coupled O2 Sensor and NO Signaling Functions. " Cell 102(4): 499-509.
67. Fabiato, A. (1983). "Calcium-Induced Release of Calcium from the Cardiac Sarcoplasmic Reticulum. " Am J Physiol 245(1): C1-14.
68. Fardeau, M. a. T., FMS (1994). Congenital Myopathies. Myology. A. E. a. C. Franzini-Armstrong. New York, McGraw Hill. 2: 1488-94.
69. Ferreiro, A., Monnier, N., Romero, N. B., Leroy, J. P., Bonnemann, C., Haenggeli, C. A., Straub, V., Voss, W. D., Nivoche, Y., Jungbluth, H., Lemainque, A., Voit, T., Lunardi, J., Fardeau, M., and Guicheney, P. (2002a). "A Recessive Form of Central Core Disease, Transiently Presenting as Multi-Minicore Disease, is Associated with a Homozygous Mutation in the Ryanodine Receptor Type 1 Gene. " Ann Neurol 51(6): 750-9.
70. Ferreiro, A., Quijano-Roy, S., Pichereau, C., Moghadaszadeh, B., Goemans, N., Bonnemann, C., Jungbluth, H., Straub, V., Villanova, M., Leroy, J. P., Romero, N. B., Martin, J. J., Muntoni, F., Voit, T., Estournet, B., Richard, P., Fardeau, M., and Guicheney, P. (2002b). "Mutations of the Selenoprotein N Gene, which is Implicated in Rigid Spine Muscular Dstrophy, Cuse the Cassical Penotype of Multiminicore Disease: Rassessing the Nsology of Early-Onset Mopathies. " Am J Hum Genet 71(4): 739-49.
71. Fiege, M., Wappler, F., Weisshorn, R., Gerbershagen, M. U., Menge, M., and Schulte Am Esch, J. (2003). "Induction of Malignant Hyperthermia in Susceptible Swine by 3, 4-Methylenedioxymethamphetamine ("Ecstasy"). " Anesthesiology 99(5): 1132-6.
72. Fill, M., and Copello, J. A. (2002). "Ryanodine Receptor Calcium Release Channels. " Physiol Rev 82(4): 893-922.
73. Fortunato, G, Berruti, R., Brancadoro, V., Fattore, M., Salvatore, F., and Carsana, A. (2000). "Identification of a Novel Mutation in the Ryanodine Receptor Gene (RYR1) in a Malignant Hyperthermia Italian Family. " Eur J Hum Genet 8(2): 149-52.
74. Franzini-Armstrong, C. (1999). "The Sarcoplasmic Reticulum and the Control of Muscle Contraction. " Faseb J 13 Suppl 2: S266-70.
75. Galli, L., Orrico, A., Cozzolino, S., Pietrini, V., Tegazzin, V., and Sorrentino, V. (2002). "Mutations in the RYR1 Gene in Italian Patients at Risk for Malignant Hyperthermia: Evidence for a Cluster of Novel Mutations in the C-Terminal Region. " Cell Calcium 32(3): 143-51.
76. Galli, L., Orrico, A., Lorenzini, S., Censini, S., Falciani, M., Covacci, A., Tegazzin, V., and Sorrentino, V. (2006). "Frequency and Localization of Mutations in the 106 Exons of the RYR1 Gene in 50 Individuals with Malignant Hyperthermia. " Hum Mutat 27(8): 830.
77. Ganguly, P. K., Pierce, G. N., Dhalla, K. S., and Dhalla, N. S. (1983). "Defective Sarcoplasmic Reticular Calcium Transport in Diabetic Cardiomyopathy. " Am J Physiol 244(6): E528-35.
78. George, C. H., Higgs, G. V., and Lai, F. A. (2003). "Ryanodine Receptor Mutations Associated with Stress-Induced Ventricular Tachycardia Mediate Increased Calcium Release in Stimulated Cardiomyocytes. " Circ Res 93(6): 531-40.
79. George, C. H., Jundi, H., Walters, N., Thomas, N. L., West, R. R., and Lai, F. A. (2006). "Arrhythmogenic Mutation-Linked Defects in Ryanodine Receptor Autoregulation Reveal a Novel Mechanism of Ca2+ Release Channel Dysfunction. " Circ Res 98(1): 88-97.
80. Gillard, E. F., Otsu, K., Fujii, J., Duff, C., de Leon, S., Khanna, V. K., Britt, B. A., Worton, R. G., and MacLennan, D. H. (1992). "Polymorphisms and Deduced Amino Acid Substitutions in the Coding Sequence of the Ryanodine Receptor (RYR1) Gene in Individuals with Malignant Hyperthermia. " Genomics 13(4): 1247-54.
81. Gillard, E. F., Otsu, K., Fujii, J., Khanna, V. K., de Leon, S., Derdemezi, J., Britt, B. A., Duff, C. L., Worton, R. G., and MacLennan, D. H. (1991). "A Substitution of Cysteine for Arginine 614 in the Ryanodine Receptor is Potentially Causative of Human Malignant Hyperthermia. " Genomics 11(3): 751-5.
82. Gonatas, N. K., Perez, M. C., Shy, G. M. and Evangelista, I. (1965). "Central "Core" Disease of Skeletal Muscle. Ultrastructural and Cytochemical Observations in Two Cases. " Am J Pathol 47: 503-24.
83. Gronert, G. (1994). Malignant Hyperthermia. Myology. A. E. a. C. Franzini-Armstrong. New York, McGraw Hill. 2: 1661-78.
84. Guis, S., Figarella-Branger, D., Monnier, N., Bendahan, D., Kozak-Ribbens, G., Mattei, J. P., Lunardi, J., Cozzone, P. J., and Pellissier, J. F. (2004). "Multiminicore Disease in a Family Susceptible to Malignant Hyperthermia: Histology, in Vitro Contracture Tests, and Genetic Characterization. " Arch Neurol 61(1): 106-13.
85. Guner, S., Arioglu, E., Tay, A., Tasdelen, A., Aslamaci, S., Bidasee, K. R., and Dincer, U. D. (2004). "Diabetes Decreases mRNA Levels of Calcium-Release Channels in Human Atrial Appendage. " Mol Cell Biochem 263(1-2): 143-50.
86. Gyorke, I., Hester, N., Jones, L. R., and Gyorke, S. (2004). "The role of Calsequestrin, Triadin, and Junctin in Conferring Cardiac Ryanodine Receptor Responsiveness to Luminal Calcium. " Biophys J 86(4): 2121-8.
87. Hackl, W., Winkler, M., Mauritz, W., Sporn, P., and Steinbereithner, K. (1991). "Muscle Biopsy for Diagnosis of Malignant Hyperthermia Susceptibility in Two Patients with Severe Exercise-Induced Myolysis. " Br J Anaesth 66(1): 138-40.
88. Haggendal, J., Jonsson, L., and Carlsten, J. (1990). "The Role of Sympathetic Activity in Initiating Malignant Hyperthermia. " Acta Anaesthesiol Scand 34(8): 677-82.
89. Haissaguerre, M., Jais, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Le Mouroux, A., Le Metayer, P., and Clementy, J. (1998). "Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins. " N Engl J Med 339(10): 659-66.
90. Hamilton, S. L., and Reid, M. B. (2000). "RyR1 Modulation by Oxidation and Calmodulin. " Antioxid Redox Signal 2(1): 41-5.
91. Hasdemir, C., Priori, S. G., Overholt, E., and Lazzara, R. (2004) "Catecholaminergic Polymorphic Ventricular Tachycardia, Recurrent Syncope, and Implantable Loop Recorder. " J Cardiovasc Electrophysiol 15(6): 729.
92. Hawkes, M. J., Nelson, T. E. and Hamilton, S. L. (1992). "3H+ Ryanodine as a Probe of Changes in the Functional State of the Ca2+-release Channel in Malignant Hyperthermia. " J. Biol. Chem. 267(10): 6702-6709.
93. Hidalgo, C. (2005). "Cross Talk Between Ca2+ and Redox Signalling Cascades in Muscle and Neurons Through the Combined Activation of Ryanodine Receptors/Ca2+ Release Channels. " Philos Trans R Soc Lond B Biol Sci 360(1464): 2237-46.
94. Hopkins, P. M. (2000). "Malignant Hyperthermia: Advances in Clinical Management and Diagnosis. " Br J Anaesth 85(1): 118-28.
95. Hove-Madsen, L., Llach, A., Bayes-Genis, A., Roura, S., Rodriguez Font, E., Aris, A., and Cinca, J. (2004). "Atrial Fibrillation is Associated with Increased Spontaneous Calcium Release from the Sarcoplasmic Reticulum in Human Atrial Myocytes. " Circulation 110(11): 1358-63.
96. Hsueh, C. H., Weng, Y. C., Chen, C. Y., Lin, T. K., Lin, Y. H., Lai, L. P., and Lin, J. L. (2006). "A Novel Mutation (Arg169Gln) of the Cardiac Ryanodine Receptor Gene Causing Exercise-Induced Bidirectional Ventricular Tachycardia. " Int J Cardiol 108(2): 276-8.
97. Huang, F., Shan, J., Reiken, S., Wehrens, X. H., and Marks, A. R. (2006). "Analysis of Calstabin2 (FKBP12. 6)-Ryanodine Receptor Interactions: Rescue of Heart Failure by Calstabin2 in Mice. " Proc Natl Acad Sci U S A 103(9): 3456-61.
98. Ibarra, M., Wu, S., Murayama, K., Minami, N., Ichihara, Y., Kikuchi, H., Noguchi, S., Hayashi, Y. K., Ochiai, R., and Nishino, I. (2006). "Malignant Hyperthermia in Japan: Mutation Screening of the Entire Ryanodine Receptor Type 1 Gene Coding Region by Direct Sequencing. " Anesthesiology 104(6): 1146-54.
99. Ikemoto, N., and Yamamoto, T. (2002). "Regulation of Calcium Release by Interdomain Interaction within Ryanodine Receptors. " Front Biosci 7: d671-83.
100. Jiang, D., Wang, R., Xiao, B., Kong, H., Hunt, D. J., Choi, P., Zhang, L., and Chen, S. R. (2005). "Enhanced Store Overload-Induced Ca2+ Release and Channel Sensitivity to Luminal Ca2+ Activation are Common Defects of RyR2 Mutations Linked to Ventricular Tachycardia and Sudden Death. " Circ Res 97(11): 1173-81.
101. Jiang, D., Xiao, B., Yang, D., Wang, R., Choi, P., Zhang, L., Cheng, H., and Chen, S. R. (2004). "RyR2 Mutations Linked to Ventricular Tachycardia and Sudden Death Reduce the Threshold for Store-Overload-Induced Ca2+ Release (SOICR). " Proc Natl Acad Sci U S A 101(35): 13062-7.
102. Jiang, D., Xiao, B., Zhang, L., and Chen, S. R. (2002). "Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (Ryanodine Receptor) Mutant Associated with Ventricular Tachycardia and Sudden Death. " Circ Res 91(3): 218-25.
103. Jungbluth, H., Muller, C. R., Halliger-Keller, B., Brockington, M., Brown, S. C., Feng, L., Chattopadhyay, A., Mercuri, E., Manzur, A. Y., Ferreiro, A., Laing, N. G., Davis, M. R., Roper, H. P., Dubowitz, V., Bydder, G., Sewry, C. A., and Muntoni, F. (2002). "Autosomal Recessive Inheritance of RYR1 Mutations in a Congenital Myopathy with Cores. " Neurology 59(2): 284-7.
104. Jurkat-Rott, K., McCarthy, T., and Lehmann-Horn, F. (2000). "Genetics and Pathogenesis of Malignant Hyperthermia. " Muscle Nerve 23(1): 4-17.
105. Kannankeril, P., Mitchell, B., Goonasekera, S., Chelu, M., Zhang, W., Sood, S., Kearney, D., Danila, C., De Beasi, M., Wehrens, X. H., Pautler, R., Roden, D., Taffet, G. E., Dirksen, R., Anderson, M. E., and Hamilton, S. L. (2006). "Mice with the R176Q Cardiac Ryanodine Receptor Mutation Exhibit Catecholamine-Induced Ventricular Tachycardia and Mild Cardiomyopathy. " Proc Natl Acad Sci U S A 103(32): 12179-12184.
106. Keating, K. E., Giblin, L., Lynch, P. J., Quane, K. A., Lehane, M., Heffron, J. J., and McCarthy, T. V. (1997). "Detection of a Novel Mutation in the Ryanodine Receptor Gene in an Irish Malignant Hyperthermia Pedigree: Correlation of the IVCT Response with the Affected and Unaffected Haplotypes. " J Med Genet 34(4): 291-6.
107. Konishi, M., Kurihara, S. and Sakai, T. (1985). "Change in Intracellular Calcium Ion Concentration Induced by Caffeine and Rapid Cooling in Frog Skeletal Muscle Fibres. " J Physiol 365: 131-46.
108. Koss, K. L., Grupp, I. L., and Kranias, E. G. (1997). "The Relative Phospholamban and SERCA2 Ratio: a Critical Determinant of Myocardial Contractility. " Basic Res Cardiol 92 Suppl 1: 17-24.
109. Lahat, H., Eldar, M., Levy-Nissenbaum, E., Bahan, T., Friedman, E., Khoury, A., Lorber, A., Kastner, D. L., Goldman, B., and Pras, E. (2001). "Autosomal Recessive Catecholamine-or Exercise-Induced Polymorphic Ventricular Tachycardia: Clinical Features and Assignment of the Disease Gene to Chromosome 1p13-21. " Circulation 103(23): 2822-7.
110. Lai, L. P., Su, M. J., Lin, J. L., Lin, F. Y., Tsai, C. H., Chen, Y. S., Huang, S. K., Tseng, Y. Z., and Lien, W. P. (1999). "Down-Regulation of L-Type Calcium Channel and Sarcoplasmic Reticular Ca(2+)-ATPase mRNA in Human Atrial Fibrillation Without Significant Change in the mRNA of Ryanodine Receptor, Calsequestrin and Phospholamban: An Insight into the Mechanism of Atrial Electrical Remodeling. " J Am Coll Cardiol 33(5): 1231-7.
111. Laitinen, P. J., Brown, K. M., Piippo, K., Swan, H., Devaney, J. M., Brahmbhatt, B., Donarum, E. A., Marino, M., Tiso, N., Viitasalo, M., Toivonen, L., Stephan, D. A., and Kontula, K. (2001). "Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia. " Circulation 103(4): 485-90.
112. Laitinen, P. J., Swan, H., and Kontula, K. (2003). "Molecular Genetics of Exercise-Induced Polymorphic Ventricular Tachycardia: Identification of Three Novel Cardiac Ryanodine Receptor Mutations and Two Common Calsequestrin 2 Amino-Acid Polymorphisms. " Eur J Hum Genet 11(11): 888-91.
113. Lamont, P. J., Dubowitz, V., Landon, D. N., Davis, M., and Morgan-Hughes, J. A. (1998). "Fifty Year Follow-Up of a Patient with Central Core Disease Shows Slow but Definite Progression. " Neuromuscul Disord 8(6): 385-91.
114. Larach, M. G. (1989). "Standardization of the Caffeine Halothane Muscle Contracture Tst. North American Malignant Hyperthermia Group. " Anesth Analg 69(4): 511-5.
115. Lehnart, S. E., Terrenoire, C., Reiken, S., Wehrens, X. H., Song, L. S., Tillman, E. J., Mancarella, S., Coromilas, J., Lederer, W. J., Kass, R. S., and Marks, A. R. (2006). "Stabilization of Cardiac Ryanodine Receptor Prevents Intracellular Calcium Leak and Arrhythmias. " Proc Natl Acad Sci U S A 103(20): 7906-10.
116. Lehnart, S. E., Wehrens, X. H., Laitinen, P. J., Reiken, S. R., Deng, S. X., Cheng, Z., Landry, D. W., Kontula, K., Swan, H., and Marks, A. R. (2004). "Sudden Death in Familial Polymorphic Ventricular Tachycardia Associated with Calcium Release Channel (Ryanodine Receptor) Leak. " Circulation 109(25): 3208-14.
117. Lehnart, S. E., Wehrens, X. H., Reiken, S., Warrier, S., Belevych, A. E., Harvey, R. D., Richter, W., Jin, S. L., Conti, M., and Marks, A. R. (2005). "Phosphodiesterase 4D Deficiency in the Ryanodine-Receptor Complex Promotes Heart Failure and Arrhythmias. " Cell 123(1): 25-35.
118. Litman, R. S., and Rosenberg, H. (2005). "Malignant Hyperthermia: Update on Susceptibility Testing. " Jama 293(23): 2918-24.
119. Liu, N., Colombi, B., Memmi, M., Zissimopoulos, S., Rizzi, N., Negri, S., Imbriani, M., Napolitano, C., Lai, F. A., and Priori, S. G. (2006). "Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: Insights from a RyR2 R4496C Knock-In Mouse Model. " Circ Res 99(3): 292-8.
120. Liu, Z., Zhang, J., Li, P., Chen, S. R., and Wagenknecht, T. (2002). "Three-Dimensional Reconstruction of the Recombinant Type 2 Ryanodine Receptor and Localization of its Divergent Region 1. " J Biol Chem 277(48): 46712-9.
121. Loke, J., and MacLennan, D. H. (1998). "Malignant Hyperthermia and Central Core Disease: Disorders of Ca2+ Release Channels. " Am J Med 104(5): 470-86.
122. Loke, J. C., Kraev, N., Sharma, P., Du, G., Patel, L., Kraev, A., and MacLennan, D. H. (2003). "Detection of a Novel Ryanodine Receptor Subtype 1 Mutation (R328W) in a Malignant Hyperthermia Family by Sequencing of a Leukocyte Transcript. " Anesthesiology 99(2): 297-302.
123. Lueck, J. D., Goonasekera, S. A., Dirksen, R. T. (2004). "Ryanodinopathies: Muscle Disorders Linked to Mutations in Ryanodine Receptors. " Bas Appl Myol (In Press).
124. Lyfenko, A., Goonasekera, S. A., and Dirksen RT (2004). "Dynamic Alterations in Myoplasmic Ca2+ in Malignant Hyperthermia and Central Core Disease. " Biochem. Biophys. Res. Commun 322(4): 1256-66.
125. Lyfenko, A. D., Ducreux, S., Wang, Y., Xu, L., Zorzato, F., Ferreiro, A., Meissner, G., Treves, S., and Dirksen, R. T. (2006). "Two Central Core Disease (CCD) Deletions in the C-Terminal Region of RYR1 Alter Muscle Excitation-Contraction (EC) Coupling by Distinct Mechanisms. " Hum Mutat.
126. Lynch, P. J., Krivosic-Horber, R., Reyford, H., Monnier, N., Quane, K., Adnet, P., Haudecoeur, G., Krivosic, I., McCarthy, T., and Lunardi, J. (1997). "Identification of Heterozygous and Homozygous Individuals with the Novel RYR1 Mutation Cys35Arg in a Large Kindred. " Anesthesiology 86(3): 620-6.
127. Lynch, P. J., Tong, J., Lehane, M., Mallet, A., Giblin, L., Heffron, J. J., Vaughan, P., Zafra, G., MacLennan, D. H., and McCarthy, T. V. (1999). "A Mutation in the Transmembrane/Luminal Domain of the Ryanodine Receptor is Associated with Abnormal Ca2+ Release Channel Function and Severe Central core Disease. " Proc Natl Acad Sci U S A 96(7): 4164-9.
128. Ma, J., Hayek, S. M., and Bhat, M. B. (2004). "Membrane Topology and Membrane Retention of the Ryanodine Receptor Calcium Release Channel. " Cell Biochem Biophys 40(2): 207-24.
129. Maccani, R. M., Wedel, D. J., and Hofer, R. E. (1996). "Norepinephrine Does Not Potentiate Porcine Malignant Hyperthermia. " Anesth Analg 82(4): 790-5.
130. Mandapati, R., Skanes, A., Chen, J., Berenfeld, O., and Jalife, J. (2000). "Stable Microreentrant Sources as a Mechanism of Atrial Fibrillation in the Isolated Sheep Heart. " Circulation 101(2): 194-9.
131. Manning, B. M., Quane, K. A., Lynch, P. J., Urwyler, A., Tegazzin, V., Krivosic-Horber, R., Censier, K., Comi, G., Adnet, P., Wolz, W., Lunardi, J., Muller, C. R., and McCarthy, T. V. (1998a). "Novel Mutations at a CpG Dinucleotide in the Ryanodine Receptor in Malignant Hyperthermia. " Hum Mutat 11(1): 45-50.
132. Manning, B. M., Quane, K. A., Ording, H., Urwyler, A., Tegazzin, V., Lehane, M., O'Halloran, J., Hartung, E., Giblin, L. M., Lynch, P. J., Vaughan, P., Censier, K., Bendixen, D., Comi, G., Heytens, L., Monsieurs, K., Fagerlund, T., Wolz, W., Heffron, J. J., Muller, C. R., and McCarthy, T. V. (1998b). "Identification of Novel Mutations in the Ryanodine-Receptor Gene (RYR1) in Malignant Hyperthermia: Genotype-Phenotype Correlation. " Am J Hum Genet 62(3): 599-609.
133. Mansour, M., Mandapati, R., Berenfeld, O., Chen, J., Samie, F. H., and Jalife, J. (2001). "Left-to-Right Gradient of Atrial Frequencies During Acute Atrial Fibrillation in the Isolated Sheep Heart. " Circulation 103(21): 2631-6.
134. Marengo, J. J., Hidalgo, C., and Bull, R. (1998). "Sulfhydryl Oxidation Modifies the Calcium Dependence of Ryanodine-Sensitive Calcium Channels of Excitable Cells. " Biophys J 74(3): 1263-77.
135. Marks, A. R. (2001). "Ryanodine Receptors/Calcium Release Channels in Heart Failure and Sudden Cardiac Death. " J Mol Cell Cardiol 33(4): 615-24.
136. Marx, S. O., Reiken, S., Hisamatsu, Y., Gaburjakova, M., Gaburjakova, J., Yang, Y. M., Rosemblit, N., and Marks, A. R. (2001). "Phosphorylation-Dependent Regulation of Ryanodine Receptors: a Novel Role for Leucine/Isoleucine Zippers. " J Cell Biol 153(4): 699-708.
137. Marx, S. O., Reiken, S., Hisamatsu, Y., Jayaraman, T., Burkhoff, D., Rosemblit, N., and Marks, A. R. (2000). "PKA Phosphorylation Dissociates FKBP12. 6 from the Calcium Release Channel (Ryanodine Receptor): Defective Regulation in Failing Hearts. " Cell 101(4): 365-76.
138. McCarthy, T. V., Quane, K. A., and Lynch, P. J. (2000). "Ryanodine Receptor Mutations in Malignant Hyperthermia and Central Core Disease. " Hum Mutat 15(5): 410-7.
139. McWilliams, S., Nelson, T., Sudo, R. T., Zapata-Sudo, G., Batti, M., and Sambuughin, N. (2002). "Novel Skeletal Muscle Ryanodine Receptor Mutation in a Large Brazilian Family with Malignant Hyperthermia. " Clin Genet 62(1): 80-3.
140. Meyers, M. B., Pickel, V. M., Sheu, S. S., Sharma, V. K., Scotto, K. W., and Fishman, G. I. (1995). "Association of Sorcin with the Cardiac Ryanodine Receptor. " J Biol Chem 270(44): 26411-8.
141. Mickelson, J. R., and Louis, C. F. (1996). "Malignant Hyperthermia: Excitation-Contraction Coupling, Ca2+ Release Channel, and Cell Ca2+ Regulation Defects. " Physiol Rev 76(2): 537-92.
142. Monnier, N., Ferreiro, A., Marty, I., Labarre-Vila, A., Mezin, P., and Lunardi, J. (2003). "A Homozygous Splicing Mutation Causing a Depletion of Skeletal Muscle RYR1 is Associated with Multi-Minicore Disease Congenital Myopathy with Ophthalmoplegia. " Hum Mol Genet 12(10): 1171-8.
143. Monnier, N., Kozak-Ribbens, G., Krivosic-Horber, R., Nivoche, Y., Qi, D., Kraev, N., Loke, J., Sharma, P., Tegazzin, V., Figarella-Branger, D., Romero, N., Mezin, P., Bendahan, D., Payen, J. F., Depret, T., Maclennan, D. H., and Lunardi, J. (2005). "Correlations Between Genotype and Pharmacological, Histological, Functional, and Clinical Phenotypes in Malignant Hyperthermia Susceptibility. " Hum Mutat 26(5): 413-25.
144. Monnier, N., Krivosic-Horber, R., Payen, J. F., Kozak-Ribbens, G., Nivoche, Y., Adnet, P., Reyford, H., and Lunardi, J. (2002). "Presence of Two Different Genetic Traits in Malignant Hyperthermia Families: Implication for Genetic Analysis, Diagnosis, and Incidence of Malignant Hyperthermia Susceptibility. " Anesthesiology 97(5): 1067-74.
145. Monnier, N., Procaccio, V., Stieglitz, P., and Lunardi, J. (1997). "Malignant-Hyperthermia Susceptibility Is Associated With Mutation of the alpha 1-Subunit of the Human Dihydropyridine-Sensitive L-Type Voltage-Dependent Calcium-Channel Receptor in Skeletal Muscle. " Am. J. Hum. Genet. 60: 1316-25.
146. Monnier, N., Romero, N. B., Lerale, J., Landrieu, P., Nivoche, Y., Fardeau, M., and Lunardi, J. (2001). "Familial and Sporadic Forms of Central Core Disease are Associated with Mutations in the C-Terminal Domain of the Skeletal Muscle Ryanodine Receptor. " Hum Mol Genet 10(22): 2581-92.
147. Monnier, N., Romero, N. B., Lerale, J., Nivoche, Y., Qi, D., MacLennan, D. H., Fardeau, M., and Lunardi, J. (2000). "An Autosomal Dominant Congenital Myopathy with Cores and Rods is Associated with a Neomutation in the RYR1 Gene Encoding the Skeletal Muscle Ryanodine Receptor. " Hum Mol Genet 9(18): 2599-608.
148. Muldoon, S., Deuster, P., Brandom, B., and Bunger, R. (2004). "Is There a Link Between Malignant Hyperthermia and Exertional Heat Illness?" Exerc Sport Sci Rev 32(4): 174-9.
149. Muntoni, F., and Sewry, C. A. (2003). "Central Core Disease: New Findings in an Old Disease. " Brain 126(Pt 11): 2339-40.
150. Nattel, S. (2002). "New Ideas About Atrial Fibrillation 50 Years On. " Nature 415(6868): 219-26.
151. Nelson, T. E. (1990). "Porcine Malignant Hyperthermia: Critical Temperatures for in Vivo and in Vitro Responses. " Anesthesiology 73(3): 449-54.
152. Netticadan, T., Temsah, R. M., Kent, A., Elimban, V., and Dhalla, N. S. (2001). "Depressed Levels of Ca2+-Cycling Proteins May Underlie Sarcoplasmic Reticulum Dysfunction in the Diabetic Heart. " Diabetes 50(9): 2133-8.
153. Ohkusa, T., Ueyama, T., Yamada, J., Yano, M., Fujumura, Y., Esato, K., and Matsuzaki, M. (1999). "Alterations in Cardiac Sarcoplasmic Reticulum Ca2+ Regulatory Proteins in the Atrial Tissue of Patients with Chronic Atrial Fibrillation. " J Am Coll Cardiol 34(1): 255-63.
154. Ording, H., Hald, A., and Sjontoft, E. (1985). "Malignant Hyperthermia Triggered by Heating in Anaesthetized Pigs. " Acta Anaesthesiol Scand 29(7): 698-701.
155. Oyamada, H., Oguchi, K., Saitoh, N., Yamazawa, T., Hirose, K., Kawana, Y., Wakatsuki, K., Tagami, M., Hanaoka, K., Endo, M., and Iino, M. (2002). "Novel Mutations in C-Terminal Channel Region of the Ryanodine Receptor in Malignant Hyperthermia Patients. " Jpn J Pharmacol 88(2): 159-66.
156. Paciello, O., Pasolini, M. P., Navas, L., Russo, V., and Papparella, S. (2006). "Myopathy with Central Cores in a Foal. " Vet Pathol 43(4): 579-83.
157. Patterson, V. H., Hill, T. R., Fletcher, P. J., and Heron, J. R. (1979). "Central Core Disease: Clinical and Pathological Evidence of Progression Within a Family. " Brain 102(3): 581-94.
158. Phrommintikul, A., and Chattipakorn, N. (2006). "Roles of Cardiac Ryanodine Receptor in Heart Failure and Sudden Cardiac Death. " Int J Cardiol 112(2): 142-52.
159. Pierce, G. N., Kutryk, M. J., and Dhalla, N. S. (1983). "Alterations in Ca2+ Binding by and Composition of the Cardiac Sarcolemmal Membrane in Chronic Diabetes. " Proc Natl Acad Sci U S A 80(17): 5412-6.
160. Pogwizd, S. M., and Bers, D. M. (2004). "Cellular Basis of Triggered Arrhythmias in Heart Failure. " Trends Cardiovasc Med 14(2): 61-66.
161. Postma, A. V., Denjoy, I., Kamblock, J., Alders, M., Lupoglazoff, J. M., Vaksmann, G., Dubosq-Bidot, L., Sebillon, P., Mannens, M. M., Guicheney, P., and Wilde, A. A. (2005). "Catecholaminergic Polymorphic Ventricular Tachycardia: RYR2 Mutations, Bradycardia, and Follow up of the Patients. " J Med Genet 42(11): 863-70.
162. Prestle, J., Janssen, P. M., Janssen, A. P., Zeitz, O., Lehnart, S. E., Bruce, L., Smith, G. L., and Hasenfuss, G. (2001). "Overexpression of FK506-Binding Protein FKBP12. 6 in Cardiomyocytes Reduces Ryanodine Receptor-Mediated Ca(2+) Leak from the Sarcoplasmic Reticulum and Increases Contractility. " Circ Res 88(2): 188-94.
163. Priori, S. G., and Napolitano, C. (2005). "Intracellular Calcium Handling Dysfunction and Arrhythmogenesis: A New Challenge for the Electrophysiologist. " Circ Res 97(11): 1077-9.
164. Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., DeSimone, L., Coltorti, F., Bloise, R., Keegan, R., Cruz Filho, F. E., Vignati, G., Benatar, A., and DeLogu, A. (2002). "Clinical and Molecular Characterization of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia. " Circulation 106(1): 69-74.
165. Priori, S. G., Napolitano, C., Tiso, N., Memmi, M., Vignati, G., Bloise, R., Sorrentino, V. V., and Danieli, G. A. (2001). "Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia. " Circulation 103(2): 196-200.
166. Quane, K. A., Healy, J. M. S., Keating, K. E., Manning, B. M., Couch, F. J., Palmucci, L. M., Doriguzzi, C., Fagerlund, T. H., Berg, K., Ording, H., Bendixen, D., Mortier, W., Linz, U., Muller, C. R., McCarthy, T. V. (1993). "Mutations in the Ryanodine Receptor Gene in Central Core Disease and Malignant Hyperthermia. " Nature Genetics 5: 51-55.
167. Quane, K. A., Keating, K. E., Healy, J. M., Manning, B. M., Krivosic-Horber, R., Krivosic, I., Monnier, N., Lunardi, J., and McCarthy, T. V. (1994). "Mutation Screening of the RYR1 Gene in Malignant Hypertherima: Detection of a Novel Tyr to Ser Mutation in a Pedigree with Associated Central Core. " Genomics 23(1): 236-9.
168. Quane, K. A., Ording, H., Keating, K. E., Manning, B. M., Heine, R., Bendixen, D., Berg, K., Krivosic-Horber, R., Lehmann-Horn, F., Fagerlund, T., and McCarthy, T. V. (1997). "Detection of a Novel Mutation at Amino Acid Position 614 in the Ryanodine Receptor in Malignant Hyperthermia. " Br J Anaesth 79(3): 332-7.
169. Quinlivan, R. M., Muller, C. R., Davis, M., Laing, N. G., Evans, G. A., Dwyer, J., Dove, J., Roberts, A. P., and Sewry, C. A. (2003). "Central Core Disease: Clinical, Pathological, and Genetic Features. " Arch Dis Child 88(12): 1051-5.
170. Reiken, S., Wehrens, X. H., Vest, J. A., Barbone, A., Klotz, S., Mancini, D., Burkhoff, D., and Marks, A. R. (2003). "Beta-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure. " Circulation 107(19): 2459-66.
171. Robinson, R., Carpenter, D., Shaw, M. A., Halsall, J., and Hopkins, P. (2006). "Mutations in RYR1 in Malignant Hyperthermia and Central Core Disease. " Hum Mutat 27(10): 977-89.
172. Rockman, H. A., Koch, W. J., and Lefkowitz, R. J. (2002). "Seven-Transmembrane-Spanning Receptors and Heart Function. " Nature 415(6868): 206-12.
173. Romero, N. B., Monnier, N., Viollet, L., Cortey, A., Chevallay, M., Leroy, J. P., Lunardi, J., and Fardeau, M. (2003). "Dominant and Recessive Central Core Disease Associated with RYR1 Mutations and Fetal Akinesia. " Brain 126(Pt 11): 2341-9.
174. Rosenberg, H., Antognini, J. F., and Muldoon, S. (2002). "Testing for Malignant Hyperthermia. " Anesthesiology 96(1): 232-7.
175. Rossi, A. E., and Dirksen, R. T. (2006). "Sarcoplasmic Reticulum: the Dynamic Calcium Governor of Muscle. " Muscle Nerve 33(6): 715-31.
176. Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., and Grishman, A. (1972). "New Type of Cardiomyopathy Associated with Diabetic Glomerulosclerosis. " Am J Cardiol 30(6): 595-602.
177. Rudolf, R., Mongillo, M., Magalhaes, P. J., and Pozzan, T. (2004). "In Vivo Monitoring of Ca(2+) Uptake into Mitochondria of Mouse Skeletal Muscle During Contraction. " J Cell Biol 166(4): 527-36.
178. Rueffert, H., Kraus, H., Olthoff, D., Deutrich, C., and Froster, U. G. (2001). "Identification of a Novel Mutation in the Ryanodine Receptor Gene (RYR1) in Patients with Malignant Hyperthermia. " Hum Mutat 17(3): 238.
179. Rueffert, H., Olthoff, D., Deutrich, C., Meinecke, C. D., and Froster, U. G. (2002). "Mutation Screening in the Ryanodine Receptor 1 Gene (RYR1) in Patients Susceptible to Malignant Hyperthermia Who Show Definite IVCT Results: Identification of Three Novel Mutations. " Acta Anaesthesiol Scand 46(6): 692-8.
180. Rueffert, H., Olthoff, D., Deutrich, C., Schober, R., and Froster, U. G. (2004). "A New Mutation in the Skeletal Ryanodine Receptor Gene (RYR1) is Potentially Causative of Malignant Hyperthermia, Central Core Disease, and Severe Skeletal Malformation. " Am J Med Genet A 124(3): 248-54.
181. Sambuughin, N., Holley, H., Muldoon, S., Brandom, B. W., de Bantel, A. M., Tobin, J. R., Nelson, T. E., and Goldfarb, L. G. (2005). "Screening of the Entire Ryanodine Receptor Type 1 Coding Region for Sequence Variants Associated with Malignant Hyperthermia Susceptibility in the North American Population. " Anesthesiology 102(3): 515-21.
182. Sambuughin, N., Nelson, T. E., Jankovic, J., Xin, C., Meissner, G., Mullakandov, M., Ji, J., Rosenberg, H., Sivakumar, K., and Goldfarb, L. G. (2001). "Identification and Functional Characterization of a Novel Ryanodine Receptor Mutation Causing Malignant Hyperthermia in North American and South American Families. " Neuromuscul Disord 11(6-7): 530-7.
183. Sambuughin, N., Sei, Y., Gallagher, K. L., Wyre, H. W., Madsen, D., Nelson, T. E., Fletcher, J. E., Rosenberg, H., and Muldoon, S. M. (2001). "North American Malignant Hyperthermia Population: Screening of the Ryanodine Receptor Gene and Identification of Novel Mutations. " Anesthesiology 95(3): 594-9.
184. Santana, L. F., Cheng, H., Gomez, A. M., Cannell, M. B., and Lederer, W. J. (1996). "Relation Between the Sarcolemmal Ca2+ Current and Ca2+ Sparks and Local Control Theories for Cardiac Excitation-Contraction Coupling. " Circ Res 78(1): 166-71.
185. Scacheri, P. C., Hoffman, E. P., Fratkin, J. D., Semino-Mora, C., Senchak, A., Davis, M. R., Laing, N. G., Vedanarayanan, V., and Subramony, S. H. (2000). "A Novel Ryanodine Receptor Gene Mutation Causing Both Cores and Rods in Congenital Myopathy. " Neurology 55(11): 1689-96.
186. Schlotthauer, K., and Bers, D. M. (2000). "Sarcoplasmic Reticulum Ca2+ Release Causes Myocyte Depolarization. Underlying Mechanism and Threshold for Triggered Action Potentials. " Circ Res 87(9): 774-80.
187. Schwartz, P. J., Stramba-Badiale, M., Segantini, A., Austoni, P., Bosi, G., Giorgetti, R., Grancini, F., Marni, E. D., Perticone, F., Rosti, D., and Salice, P. (1998). "Prolongation of the QT Interval and the Sudden Infant Death Syndrome. " N Engl J Med 338(24): 1709-14.
188. Scoote, M., and Williams, A. J. (2002). "The Cardiac Ryanodine Receptor (Calcium Release Channel): Emerging Role in Heart Failure and Arrhythmia Pathogenesis. " Cardiovasc Res 56(3): 359-72.
189. Seals, D. R., and Victor, R. G. (1991). "Regulation of Muscle Sympathetic Nerve Activity During Exercise in Humans. " Exerc Sport Sci Rev 19: 313-49.
190. Sei, Y., Gallagher, K. L., and Basile, A. S. (1999). "Skeletal Muscle Type Ryanodine Receptor is Involved in Calcium Signaling in Human B Lymphocytes. " J Biol Chem 274(9): 5995-6002.
191. Sei, Y., Sambuughin, N., and Muldoon, S. (2004). "Malignant Hyperthermia Genetic Testing in North America Working Group Meeting. Bethesda, Maryland. September 4-5, 2002. " Anesthesiology 100(2): 464-5.
192. Sembrowich, W. L., Quintinskie, J. J., and Li, G. (1985). "Calcium Uptake in Mitochondria from Different Skeletal Muscle Types. " J Appl Physiol 59(1): 137-41.
193. Sewry, C. A., Muller, C., Davis, M., Dwyer, J. S., Dove, J., Evans, G., Schroder, R., Furst, D., Helliwell, T., Laing, N., and Quinlivan, R. C. (2002). "The Spectrum of Pathology in Central Core Disease. " Neuromuscul Disord 12(10): 930-8.
194. Shah, P. K., and Sowdhamini, R. (2001). "Structural Understanding of the Transmembrane Domains of Inositol Triphosphate Receptors and Ryanodine Receptors Towards Calcium Channeling. " Protein Eng 14(11): 867-74.
195. Shepherd, S., Ellis, F., Halsall, J., Hopkins, P., and Robinson, R. (2004). "RYR1 Mutations in UK Central Core Disease Patients: More Than Just the C-Terminal Transmembrane Region of the RYR1 Gene. " J Med Genet 41(3): e33.
196. Shuaib, A., Paasuke, R. T., and Brownell, K. W. (1987). "Central Core Disease. Clinical Features in 13 Patients. " Medicine (Baltimore) 66(5): 389-96.
197. Shy, G. M., and Magee, K. R. (1956). "A New Congenital Non-Progressive Myopathy. " Brain 79: 610-621.
198. Smith, J., Coronado, R., and Meissner, G. (1986). "Single Channel Measurements of Calcium Release Channel from Skeletal Muscle Sarcoplasmic Reticulum. " J. Gen. Physiol. 88: 573-588.
199. Smith, J. S., Imagawa, T., Ma, J., Fill, M., Campbell, K. P., and Coronado, R. (1988). "Purified Ryanodine Receptor from Rabbit Skeletal Muscle is the Calcium-Release Channel of Sarcoplasmic Reticulum. " J Gen Physiol 92(1): 1-26.
200. Strazis, K. P., and Fox, A. W. (1993). "Malignant Hyperthermia: a Review of Published Cases. " Anesth Analg 77(2): 297-304.
201. Sumitomo, N., Harada, K., Nagashima, M., Yasuda, T., Nakamura, Y., Aragaki, Y., Saito, A., Kurosaki, K., Jouo, K., Koujiro, M., Konishi, S., Matsuoka, S., Oono, T., Hayakawa, S., Miura, M., Ushinohama, H., Shibata, T., and Niimura, I. (2003). "Catecholaminergic Polymorphic Ventricular Tachycardia: Electrocardiographic Characteristics and Optimal Therapeutic Strategies to Prevent Sudden Death. " Heart 89(1): 66-70.
202. Sun, H., Gaspo, R., Leblanc, N., and Nattel, S. (1998). "Cellular Mechanisms of Atrial Contractile Dysfunction Caused by Sustained Atrial Tachycardia. " Circulation 98(7): 719-27.
203. Tammaro, A., Bracco, A., Cozzolino, S., Esposito, M., Di Martino, A., Savoia, G., Zeuli, L., Piluso, G., Aurino, S., and Nigro, V. (2003). "Scanning for Mutations of the Ryanodine Receptor (RYR1) Gene by Denaturing HPLC: Detection of Three Novel Malignant Hyperthermia Alleles. " Clin Chem 49(5): 761-8.
204. Terentyev, D., Nori, A., Santoro, M., Viatchenko-Karpinski, S., Kubalova, Z., Gyorke, I., Terentyeva, R., Vedamoorthyrao, S., Blom, N. A., Valle, G., Napolitano, C., Williams, S. C., Volpe, P., Priori, S. G., and Gyorke, S. (2006). "Abnormal Interactions of Calsequestrin with the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death. " Circ Res 98(9): 1151-8.
205. Terentyev, D., Viatchenko-Karpinski, S., Gyorke, I., Volpe, P., Williams, S. C., and Gyorke, S. (2003). "Calsequestrin Determines the Functional Size and Stability of Cardiac Intracellular Calcium Stores: Mechanism for Hereditary Arrhythmia. " Proc Natl Acad Sci U S A 100(20): 11759-64.
206. Teshima, Y., Takahashi, N., Saikawa, T., Hara, M., Yasunaga, S., Hidaka, S., and Sakata, T. (2000). "Diminished Expression of Sarcoplasmic Reticulum Ca2+-ATPase and Ryanodine Sensitive Ca2+ Channel mRNA in Streptozotocin-Induced Diabetic Rat Heart. " J Mol Cell Cardiol 32(4): 655-64.
207. Tester, D. J., and Ackerman, M. J. (2006a). "The Role of Molecular Autopsy in Unexplained Sudden Cardiac Death. " Curr Opin Cardiol 21(3): 166-72.
208. Tester, D. J., Carturan, E., Dura, M., Reiken, S., Wronska, A., Marks, A. R., and Ackerman, M. J. (2006b). "Molecular and Functional Characterization of Novel RyR2-Encoded Cardiac Ryanodine Receptor/Calcium Release Channel Mutations in Sudden Infant Death Syndrome. " Heart Rhythm 3(5-S1): S67.
209. Tester, D. J., Kopplin, L. J., Will, M. L., and Ackerman, M. J. (2005). "Spectrum and Prevalence of Cardiac Ryanodine Receptor (RyR2) Mutations in a Cohort of Unrelated Patients Referred Explicitly for Long QT Syndrome Genetic Testing. " Heart Rhythm 2(10): 1099-105.
210. Tester, D. J., Spoon, D. B., Valdivia, H. H., Makielski, J. C., and Ackerman, M. J. (2004). "Targeted Mutational Analysis of the RyR2-Encoded Cardiac Ryanodine Receptor in Sudden Unexplained Death: a Molecular Autopsy of 51 Medical Examiner/Coroner's Cases. " Mayo Clin Proc 79(11): 1380-4.
211. Thomas, N. L., George, C. H., and Lai, F. A. (2004). "Functional Heterogeneity of Ryanodine Receptor Mutations Associated with Sudden Cardiac Death. " Cardiovasc Res 64(1): 52-60.
212. Thomas, N. L., Lai, F. A., and George, C. H. (2005). "Differential Ca2+ Sensitivity of RyR2 Mutations Reveals Distinct Mechanisms of Channel Dysfunction in Sudden Cardiac Death. " Biochem Biophys Res Commun 331(1): 231-8.
213. Tilgen, N., Zorzato, F., Halliger-Keller, B., Muntoni, F., Sewry, C., Palmucci, L. M., Schneider, C., Hauser, E., Lehmann-Horn, F., Muller, C. R., and Treves, S. (2001). "Identification of four Novel Mutations in the C-Terminal Membrane Spanning Domain of the Ryanodine Receptor 1: Association with Central Core Disease and Alteration of Calcium Homeostasis. " Hum Mol Genet 10(25): 2879-87.
214. Tiso, N., Stephan, D. A., Nava, A., Bagattin, A., Devaney, J. M., Stanchi, F., Larderet, G., Brahmbhatt, B., Brown, K., Bauce, B., Muriago, M., Basso, C., and G. Thiene, Danieli, G. A., and Rampazzo, A. (2001). "Identification of Mutations in the Cardiac Ryanodine Receptor Gene in Families Affected with Arrhythmogenic Right Ventricular Cardiomyopathy Ttype 2 (ARVD2). " Hum Mol Genet 10(3): 189-94.
215. Tiziana di Gioia, C. R., Autore, C., Romeo, D. M., Ciallella, C., Aromatario, M. R., Lopez, A., Pagannone, E., Giordano, C., Gallo, P., and d'Amati, G. (2006). "Sudden Cardiac Death in Younger Adults: Autopsy Diagnosis as a Tool for Preventive Medicine. " Hum Pathol 37(7): 794-801.
216. Tong, J., McCarthy, T. V., and MacLennan, D. H. (1999). "Measurement of Resting Cytosolic Ca2+ Concentrations and Ca2+ Store Size in HEK-293 Cells Transfected with Malignant Hyperthermia or Central Core Disease Mutant Ca2+ Release Channels. " J Biol Chem 274(2): 693-702.
217. Tong, J., Oyamada, H., Demaurex, N., Grinstein, S., McCarthy, T. V., and MacLennan, D. H. (1997). "Caffeine and Halothane Sensitivity of Intracellular Ca2+ Release Is Altered by 15 Calcium Release Channel (Ryanodine Receptor) Mutations Associated with Malignant Hyperthermia and/or Central Core Disease. " J. Biol. Chem. 272(42): 26332-26339.
218. Trafford, A. W., Diaz, M. E., O'Neill, S. C., and Eisner, D. A. (2002). "Integrative Analysis of Calcium Signalling in Cardiac Muscle. " Front Biosci 7: d843-52.
219. Treves, S., Anderson, A. A., Ducreux, S., Divet, A., Bleunven, C., Grasso, C., Paesante, S., and Zorzato, F. (2005). "Ryanodine Receptor 1 Mutations, Dysregulation of Calcium Homeostasis and Neuromuscular Disorders. " Neuromuscul Disord 15(9-10): 577-87.
220. Tripathy, A., and Meissner, G. (1996). "Sarcoplasmic Reticulum Lumenal Ca2+ has Access to Cytosolic Activation and Inactivation Sites of Skeletal Muscle Ca2+ Release Channel. " Biophys J 70(6): 2600-15.
221. Van Wagoner, D. R., Pond, A. L., Lamorgese, M., Rossie, S. S., McCarthy, P. M., and Nerbonne, J. M. (1999). "Atrial L-Type Ca2+ Currents and Human Atrial Fibrillation. " Circ Res 85(5): 428-36.
222. Vest, J. A., Wehrens, X. H., Reiken, S. R., Lehnart, S. E., Dobrev, D., Chandra, P., Danilo, P., Ravens, U., Rosen, M. R., and Marks, A. R. (2005). "Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation. " Circulation 111(16): 2025-32.
223. Wappler, F., Fiege, M., Steinfath, M., Agarwal, K., Scholz, J., Singh, S., Matschke, J., and Schulte Am Esch, J. (2001). "Evidence for Susceptibility to Malignant Hyperthermia in Patients with Exercise-Induced Rhabdomyolysis. " Anesthesiology 94(1): 95-100.
224. Wehner, M., Rueffert, H., Koenig, F., and Olthoff, D. (2003a). "Calcium Release from A Sarcoplasmic Reticulum is Facilitated in Human Myotubes Derived from Carriers of the Ryanodine Receptor Type 1 Mutations Ile2182Phe and Gly2375Ala. " Genet Test 7(3): 203-11.
225. Wehner, M., Rueffert, H., Koenig, F., and Olthoff, D. (2004). "Functional Characterization of Malignant Hyperthermia-Associated RyR1 Mutations in Exon 44, using the Human Myotube Model. " Neuromuscul Disord 14(7): 429-37.
226. Wehrens, X. H., and Marks, A. R. (2003b). "Altered Function and Regulation of Cardiac Ryanodine Receptors in Cardiac Disease. " Trends Biochem Sci 28(12): 671-8.
227. Wehrens, X. H., and Marks, A. R. (2004a). "Novel Therapeutic Approaches for Heart Failure by Normalising Calcium Cycling. " Nat Rev Drug Discov 3: 565-73.
228. Wehrens, X. H., and Marks, A. R. (2004b). "Sudden Unexplained Death Caused by Cardiac Ryanodine Receptor (RyR2) Mutations. " Mayo Clin Proc 79(11): 1367-71.
229. Wehrens, X. H., Lehnart, S. E., and Marks, A. R. (2005a). "Ryanodine Receptor-Targeted Anti-Arrhythmic Therapy. " Ann N Y Acad Sci 1047: 366-75.
230. Wehrens, X. H., Lehnart, S. E., Huang, F., Vest, J. A., Reiken, S. R., Mohler, P. J., Sun, J., Guatimosim, S., Song, L. S., Rosemblit, N., D'Armiento, J. M., Napolitano, C., Memmi, M., Priori, S. G., Lederer, W. J., and Marks, A. R. (2003). "FKBP12. 6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death. " Cell 113(7): 829-40.
231. Wehrens, X. H. T., Lehnart, S. E., and Marks, A. R. (2005b). "Intracellular Calcium Release Channels and Cardiac Disease. " Annu Rev Physiol 67: 69-98.
232. Wu, S., Ibarra, M. C., Malicdan, M. C., Murayama, K., Ichihara, Y., Kikuchi, H., Nonaka, I., Noguchi, S., Hayashi, Y. K., and Nishino, I. (2006). "Central Core Disease is Due to RYR1 Mutations in More Than 90% of Patients. " Brain 129(Pt 6): 1470-80.
233. Yang, T., Ta, T. A., Pessah, I. N., and Allen, P. D. (2003). "Functional Defects in Six Ryanodine Receptor Isoform-1 (RyR1) Mutations Associated with Malignant Hyperthermia and their Impact on Skeletal Excitation-Contraction Coupling. " J Biol Chem 278(28): 25722-30.
234. Yang, Z., Ikemoto, N., Lamb, G. D., and Steele, D. S. (2006). "The RyR2 Central Domain Peptide DPc10 Lowers the Threshold for Spontaneous Ca2+ Release in Permeabilized Cardiomyocytes. " Cardiovasc Res 70(3): 475-85.
235. Yano, M., Yamamoto, T., Ikeda, Y., and Matsuzaki, M. (2006). "Mechanisms of Disease: Ryanodine Receptor Defects in Heart Failure and Fatal Arrhythmia. " Nat Clin Pract Cardiovasc Med 3(1): 43-52.
236. Yaras, N., and Turan, B. (2005). "Interpretation of Relevance of Sodium-Calcium Exchange in Action Potential of Diabetic Rat Heart by Mathematical Model. " Mol Cell Biochem 269(1-2): 121-9.
237. Yaras, N., Ugur, M., Ozdemir, S., Gurdal, H., Purali, N., Lacampagne, A., Vassort, G., and Turan, B. (2005). "Effects of Diabetes on Ryanodine Receptor Ca Release Channel (RyR2) and Ca2+ Homeostasis in Rat Heart. " Diabetes 54(11): 3082-8.
238. Yeh, H. M., Tsai, M. C., Su, Y. N., Shen, R. C., Hwang, J. J., Sun, W. Z., and Lai, L. P. (2005). "Denaturing high Performance Liquid Chromatography Screening of Ryanodine Receptor Type 1 Gene in Patients with Malignant Hyperthermia in Taiwan and Identification of a Novel Mutation (Y522C). " Anesth Analg 101(5): 1401-6.
239. Yu, Z., and McNeill, J. H. (1991). "Force-Interval Relationship and its Response to Ryanodine in Streptozotocin-Induced Diabetic Rats. " Can J Physiol Pharmacol 69(9): 1268-76.
240. Yu, Z., Tibbits, G. F., and McNeill, J. H. (1994). "Cellular Functions of Diabetic Cardiomyocytes: Contractility, Rapid-Cooling Contracture, and Ryanodine Binding. " Am J Physiol 266(5 Pt 2): H2082-9.
241. Yue, L., Melnyk, P., Gaspo, R., Wang, Z., and Nattel, S. (1999). "Molecular Mechanisms Underlying Ionic Remodeling in a Dog Model of Atrial Fibrillation. " Circ Res 84(7): 776-84.
242. Zhang, H., Zhang, J. Z., Danila, C. I., and Hamilton, S. L. (2003). "A Noncontiguous, Inter-Subunit Binding Site for Calmodulin on the Skeletal Muscle Ca2+ Release Channel. " J Biol Chem 278(10): 8348-55.
243. Zhang, J.-Z., Wu, Y., Williams, B. Y., Rodney, G., Mandel, F., Strasburg, G. M. and Hamilton, S. L. (1999). "Oxidation of the Skeletal Muscle Ca2+Release Channel Alters Calmodulin Binding. " Am. J. Physiol. 276(1 Pt. 1): C46-C53.
244. Zhang, L., Kelley, J., Schmeisser, G., Kobayashi, Y. M., and Jones, L. R. (1997). "Complex Formation Between Junctin, Triadin, Calsequestrin, and the Ryanodine Receptor. Proteins of the Cardiac Junctional Sarcoplasmic. reticulum membrane. " J Biol Chem 272(37): 23389-97.
245. Zhang, Y., Chen, H. S., Khanna, V. K. De Leon, S., Phillips, M. S., Schappert, K., Britt, B. A., Brownell, A. K., and MacLennan, D. H., (1993). "A Mutation in the Human Ryanodine Receptor Gene Associated with Central Core Disease. " Nature Genetics 5: 46-50.
246. Zhong, Y., Ahmed, S., Grupp, I. L., and Matlib, M. A. (2001). "Altered SR Protein Expression Associated with Contractile Dysfunction in Diabetic Rat Hearts. " Am J Physiol Heart Circ Physiol 281(3): H1137-47.
247. Zhou H, Y. N., Xu L, Wang Y, Sewry C, Jungbluth H, Zorzato F, Bertini E, and M. G. Muntoni F, Treves S. (2006). "Characterization of Recessive RYR1 Mutations in Core Myopathies. " Hum Mol Genet 15(18): 2791-803.
248. Zorzato, F., Yamaguchi, N., Xu, L., Meissner, G., Muller, C. R., Pouliquin, P., Muntoni, F., Sewry, C., Girard, T., andTreves, S. (2003). "Clinical and Functional Effects of a Deletion in a COOH-Terminal Lumenal Loop of the Skeletal Muscle Ryanodine Receptor. " Hum Mol Genet 12(4): 379-88.